Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

Antonio Vitale^#^{1

2}, Judith Palacios-Olid^#³, Valeria Caggiano^{1

2}, Gaafar Ragab^{4

5}, José Hernández-Rodríguez⁶, Laura Pelegrín⁶, Germán Mejía-Salgado⁷, Laura Zarate-Pinzón⁷, Stefano Gentileschi^{1

2}, Jurgen Sota^{1

2}, Alex Fonollosa⁸, Ester Carreño^{9

10}, Carla Gaggiano^{1

2}, Rana Hussein Amin¹¹, Alberto Balistreri^{2

12}, Javier Narváez³, Gian Marco Tosi¹³, Bruno Frediani^{1

2}, Luca Cantarini^{1

2}, Alejandra de-la-Torre⁷, Claudia Fabiani^{2

13}

Affiliations

¹ Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
² Azienda Ospedaliero-Universitaria Senese [European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], Siena, Italy.
³ Rheumatology Department, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
⁴ Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt.
⁵ Faculty of Medicine, Newgiza University, 6th of October City, Egypt.
⁶ Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clínic of Barcelona [European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], University of Barcelona, Barcelona, Spain.
⁷ Neuroscience Research Group (NEUROS), NeuroVitae Center, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
⁸ Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.
⁹ Department of Ophthalmology, Hospital Universitario Rey Juan Carlos, Madrid, Spain.
¹⁰ Department of Ophthalmology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
¹¹ Department of Ophthalmology, Cairo University, Giza, Egypt.
¹² Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
¹³ Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.

^# Contributed equally.

PMID: 39346944
PMCID: PMC11427952
DOI: 10.3389/fmed.2024.1489092

Published Erratum

Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

Antonio Vitale et al. Front Med (Lausanne). 2024.

. 2024 Sep 13:11:1489092.

doi: 10.3389/fmed.2024.1489092. eCollection 2024.

Authors

Affiliations

¹ Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
² Azienda Ospedaliero-Universitaria Senese [European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], Siena, Italy.
³ Rheumatology Department, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
⁴ Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt.
⁵ Faculty of Medicine, Newgiza University, 6th of October City, Egypt.
⁶ Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clínic of Barcelona [European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], University of Barcelona, Barcelona, Spain.
⁷ Neuroscience Research Group (NEUROS), NeuroVitae Center, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
⁸ Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.
⁹ Department of Ophthalmology, Hospital Universitario Rey Juan Carlos, Madrid, Spain.
¹⁰ Department of Ophthalmology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
¹¹ Department of Ophthalmology, Cairo University, Giza, Egypt.
¹² Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
¹³ Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.

^# Contributed equally.

PMID: 39346944
PMCID: PMC11427952
DOI: 10.3389/fmed.2024.1489092

Abstract

[This corrects the article DOI: 10.3389/fmed.2024.1439338.].

Keywords: baricitinib; scleritis; tofacitinib; upadacitinib; uveitis.

Copyright © 2024 Vitale, Palacios-Olid, Caggiano, Ragab, Hernández-Rodríguez, Pelegrín, Mejía-Salgado, Zarate-Pinzón, Gentileschi, Sota, Fonollosa, Carreño, Gaggiano, Amin, Balistreri, Narváez, Tosi, Frediani, Cantarini, de-la-Torre and Fabiani.

PubMed Disclaimer

Figures

**Figure 1**
Flow-chart explaining the selection of patients included in this study starting from the total number of patients included in the AutoInflammatory Disease Alliance (AIDA) Network project.

See this image and copyright information in PMC

Erratum for

Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries.
Vitale A, Palacios-Olid J, Caggiano V, Ragab G, Hernández-Rodríguez J, Pelegrín L, Mejía-Salgado G, Zarate-Pinzón L, Gentileschi S, Sota J, Fonollosa A, Carreño E, Gaggiano C, Amin RH, Balistreri A, Narváez J, Tosi GM, Frediani B, Cantarini L, de-la-Torre A, Fabiani C. Vitale A, et al. Front Med (Lausanne). 2024 Aug 23;11:1439338. doi: 10.3389/fmed.2024.1439338. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39247640 Free PMC article.

Publication types

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

Affiliations

Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

Authors

Affiliations

Abstract

Figures

Erratum for

Publication types